Hershberg Robert Insider Trades

Insider Trading History

Track insider trading activity for Hershberg Robert. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Director
Holding Value $997k 62,347 shares
Last Trade
Mar 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$257k 15,625 shares
$16.44
$15.99
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Director
Holding Value $747k 46,722 shares
Last Trade
Dec 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$367k 22,968 shares
$16.00
$15.99
ATAI Life Sciences N.V.
ATAI Life Sciences N.V. ATAI
Director
Holding Value $2.07M 456,011 shares
Last Trade
Nov 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.22M 719,121 shares
$4.48
$4.53
HilleVax
HilleVax HLVX
President And CEO
Holding Value $0 0 shares
Last Trade
Sep 17, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$2.15M 1,101,498 shares
$1.95
$2.09
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $256k 73,732 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 44,031 shares
$5.11
$3.47
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Director
Holding Value $1.11M 69,690 shares
Last Trade
Mar 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$402k 53,000 shares
$7.59
$15.99
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Director
Holding Value $1.96M 122,690 shares
Last Trade
Mar 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$193k 23,726 shares
$8.12
$15.99
HilleVax
HilleVax HLVX
See Remarks
Holding Value $2.3M 1,101,498 shares
Last Trade
Feb 11, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$20.9k 11,901 shares
$1.76
$2.09
HilleVax
HilleVax HLVX
See Remarks
Holding Value $2.33M 1,113,399 shares
Last Trade
Feb 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$27.7k 14,634 shares
$1.89
$2.09
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $179k 51,716 shares
Last Trade
Jun 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 26,193 shares
$8.59
$3.47
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Director
Holding Value $1.72M 107,296 shares
Last Trade
Mar 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$192k 48,044 shares
$3.99
$15.99
HilleVax
HilleVax HLVX
See Remarks
Holding Value $2.36M 1,128,033 shares
Last Trade
Feb 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.42M 226,885 shares
$15.06
$2.09
HilleVax
HilleVax HLVX
See Remarks
Holding Value $1.99M 953,831 shares
Last Trade
Feb 08, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$173k 11,597 shares
$14.93
$2.09
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $87.5k 25,224 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 25,224 shares
$8.92
$3.47
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $134k 38,619 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 12,612 shares
$8.92
$3.47
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $88.8k 40,000 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 40,000 shares
$5.52
$2.22
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Director
Holding Value $1.21M 75,968 shares
Last Trade
Mar 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$197k 23,329 shares
$8.46
$15.99
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Director
Holding Value $978k 61,193 shares
Last Trade
Feb 02, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$522k 53,000 shares
$9.85
$15.99
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Director
Holding Value $0 0 shares
Last Trade
Feb 02, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$522k 53,000 shares
$9.85
$15.99
HilleVax
HilleVax HLVX
President And CEO
Holding Value $2.02M 965,428 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.88M 381,950 shares
$18.00
$2.09

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up